<?xml version="1.0" encoding="UTF-8" ?>
    <rss version="2.0">
      <channel>
        <title>PeptideUnicorn FDA Tracker Updates</title>
        <link>https://peptideunicorn.com/tracker/</link>
        <description>Editorial updates from the PeptideUnicorn FDA peptide compounding watchlist.</description>
        <language>en</language>
        
        <item>
          <title><![CDATA[KPV added to PCAC tracker coverage]]></title>
          <link>https://peptideunicorn.com/tracker/#kpv-pcac-row-added</link>
          <guid>https://peptideunicorn.com/tracker/#kpv-pcac-row-added</guid>
          <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
          <description><![CDATA[Row-level tracker audit added KPV because FDA's July 2026 PCAC notice lists KPV-related bulk drug substances for discussion.]]></description>
        </item>
      
        <item>
          <title><![CDATA[Tracker language updated to FDA source signals]]></title>
          <link>https://peptideunicorn.com/tracker/#tracker-source-language-updated</link>
          <guid>https://peptideunicorn.com/tracker/#tracker-source-language-updated</guid>
          <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
          <description><![CDATA[PeptideUnicorn replaced forecast-style category labels with source-based signals: PCAC review, FDA safety-risk page, Category 3, route-specific, approved-drug context, and monitor.]]></description>
        </item>
      
        <item>
          <title><![CDATA[FDA posts July 2026 PCAC peptide agenda]]></title>
          <link>https://peptideunicorn.com/tracker/#pcac-july-2026-peptide-meeting</link>
          <guid>https://peptideunicorn.com/tracker/#pcac-july-2026-peptide-meeting</guid>
          <pubDate>Thu, 28 May 2026 00:00:00 GMT</pubDate>
          <description><![CDATA[FDA's July 23-24, 2026 PCAC notice covers BPC-157, KPV, TB-500, MOTs-C, DSIP, Semax, and Epitalon-related bulk drug substances.]]></description>
        </item>
      
        <item>
          <title><![CDATA[GHK-Cu route-specific 503A status updated]]></title>
          <link>https://peptideunicorn.com/tracker/#ghk-cu-route-specific-update</link>
          <guid>https://peptideunicorn.com/tracker/#ghk-cu-route-specific-update</guid>
          <pubDate>Thu, 14 May 2026 00:00:00 GMT</pubDate>
          <description><![CDATA[FDA's May 14, 2026 503A PDF adds GHK-Cu, except injectable routes of administration, back to Category 1 after a nominator clarified the withdrawal scope.]]></description>
        </item>
      
      </channel>
    </rss>